InMed Pharmaceuticals Added to CSE25 Index

- September 21st, 2017

InMed Pharmaceuticals announced that it has been included in the CSE25 Index.

InMed Pharmaceuticals (CSE:IN; OTCQB:IMLFF) announced that it has been included in the CSE25 Index.
As quoted in the press release:

InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index.

About the CSE25 Index
On September 18, 2017, the Canadian Securities Exchange (“CSE”) announced the introduction of a new index comprised of the securities of the largest companies trading on the exchange.

Click here to read the full press release.

Source: www.newswire.ca

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select None
Select All

Leave a Reply